CompletedPhase 2NCT03029091

An Open-Label Trial of Losartan Potassium in Participants With Eosinophilic Esophagitis (EoE)

Studying NON RARE IN EUROPE: Eosinophilic esophagitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Marc E Rothenberg, MD, PhD
Children's Hospital Medical Center, Cincinnati
Intervention
Losartan Potassium(drug)
Enrollment
15 enrolled
Eligibility
5-25 years · All sexes
Timeline
20172019

Study locations (3)

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · National Institute of Allergy and Infectious Diseases (NIAID) · Office of Rare Diseases (ORD) · National Center for Advancing Translational Sciences (NCATS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03029091 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Eosinophilic esophagitis

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Eosinophilic esophagitis

← Back to all trials